China Signals More Pressure on Drug Prices in 2016 Policies

Drug companies operating in China can expect more pressure on prices this year after the central government laid out its priorities for medical reform and highlighted its focus on curbing the cost of medicines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.